Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,973
datasets available to search
ShareScore release 0.9.0
Dataset results
1,973 results for “T cell receptor”
VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway
ClinicalTrials.gov study NCT01892072. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fetal Cell Receptors Repertoire
ClinicalTrials.gov study NCT06031714. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF
ClinicalTrials.gov study NCT03047746. IPD Sharing: NO. Countries: 1. Publications: 0.
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
ClinicalTrials.gov study NCT06182696. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
ClinicalTrials.gov study NCT06688799. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)
ClinicalTrials.gov study NCT02332512. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
ClinicalTrials.gov study NCT07297667. IPD Sharing: YES. Countries: 0. Publications: 0.
To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete T
ClinicalTrials.gov study NCT04853342. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL
ClinicalTrials.gov study NCT05907603. IPD Sharing: NO. Countries: 1. Publications: 0.
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
ClinicalTrials.gov study NCT05044039. IPD Sharing: NO. Countries: 1. Publications: 0.
Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome
ClinicalTrials.gov study NCT06895473. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT03082300. IPD Sharing: NO. Countries: 1. Publications: 0.
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
ClinicalTrials.gov study NCT06865664. IPD Sharing: YES. Countries: 1. Publications: 0.
Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors
ClinicalTrials.gov study NCT03391791. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy
ClinicalTrials.gov study NCT06552572. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy
ClinicalTrials.gov study NCT05640713. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cell
ClinicalTrials.gov study NCT07042438. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Serial Changes of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) Levels in Patients With Acute Respiratory Distress Syndrome
ClinicalTrials.gov study NCT00557414. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
ClinicalTrials.gov study NCT06186401. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies
ClinicalTrials.gov study NCT04011293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.